A high rate of polypharmacy is, in part, a consequence of the increasing proportion of
multimorbidity in the ageing population worldwide. Our understanding of the potential harm …

Background Inappropriate polypharmacy is a particular concern in older people and is
associated with negative health outcomes. Choosing the best interventions to improve …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are the backbone of
osteoarthritis pain management. We aimed to assess the effectiveness of different …

Objective To summarise the findings of an updated Cochrane review of interventions aimed
at improving the appropriate use of polypharmacy in older people. Design Cochrane …

Aims To synthesise associations of potentially inappropriate prescribing (PIP) with health‐
related and system‐related outcomes in inpatient hospital settings. Methods Six electronic …

Background Potentially inappropriate prescribing (PIP) is one of the main risk factors for
adverse drug events (ADEs) in older people. Purpose This systematic literature review aims …

The use of multiple medicines (polypharmacy) is increasingly common in middle-aged and
older populations. Ensuring the correct balance between the prescribing of 'many'drugs and …

What is known and Objective Potentially inappropriate prescribing (PIP) has significant
clinical, humanistic and economic impacts. Identifying PIP in older adults may reduce their …

Inappropriate prescribing is particularly common in older patients and is associated with
adverse drug events (ADEs), hospitalization, and wasteful utilization of resources. We …

The older population, composed of adults aged 65 years or older, is the fastest growing
segment of the United States population. The Administration of Aging of the United States …